| SARS-CoV-1 | Severe Acute Respiratory Syndrome Coronavirus-1 |
| MERS-CoV | Middle East Respiratory Syndrome Coronavirus |
| SARS-CoV-2 | Severe Acute Respiratory Syndrome Coronavirus-2 |
| COVID-19 | Coronavirus disease emerged in 2019 |
| WHO | World Health Organization |
| ACE2 | Angiotensin-Converting enzyme 2 |
| MRI | Magnetic Resonance Imaging |
| NSAID | Non-steroidal anti-inflammatory drug |
| NO | Nitric Oxide |
| OA | Osteoarthritis |
| iNOS | Inducible nitric oxide synthase |
| COX-2 | Cyclooxygenase 2 |
| PGE2 | Prostaglandin E2 |
| RAS | Renin-angiotensin system |
| IL-6 | Interleukin 6 |
| IL-1β | Interleukin 1 beta |
| TNFα | Tumor necrosis factor alfa |
| SASP | Senescence-associated secretory phenotype |
| CCL2/3/4 | C–C motif chemokine ligand 2/3/4 |
| CXCL2 | Chemokine (C-X-C motif) ligand 2 |
| Peptide hormone EREG | Protein encoded by EREG gene, epiregulin |
| DRG | Dorsal root ganglia |
| AT1R | Angiotensin II type 1 receptor |
| PI3K | Phosphoinositide 3-kinase |
| MAPKs | Mitogen-activated protein kinase |
| JNK | c-Jun N-terminal kinases |
| ARB | Angiotensin receptor blocker |
| AT1R blocker | Angiotensin II type I receptor blocker |
| AT2R | Angiotensin II type 2 receptor |
| ACEI | Angiotensin-converting enzyme inhibitor |
| TMPRSS2 | Transmembrane serine protease 2 |
| Bmal1 | Brain and muscle Arnt-like protein-1 |
| Angiotensin (1–7)/MAS axis | Angiotensin (1–7)/ mitochondrial assembly receptor axis |
| COPD | Chronic obstructive pulmonary disease |
| nAchR | Nicotinic acetylcholine receptor |
| CHRNA7 | Gene for the Cholinergic Receptor Nicotinic Alpha 7 Subunit |
| α7nAchR | Alfa7 nicotinic acetylcholine receptor |
| CHRFAM7A | human partial duplication of the CHRNA7 gene which encodes for the α7nAchR |